fbpx
Connect with us

Health

FDA panel recommends more clinical data on AstraZeneca drug

Published

on

Food_and_Drug_Administration_(United_States)_(logo)

[REUTERS]

(Reuters) – An advisory panel to the U.S. Food and Drug Administration recommended on Wednesday that AstraZeneca Plc be required to submit further clinical data before its experimental ovarian cancer drug is approved.

The panel voted 11-2 that the company should complete a second trial to confirm results seen in a smaller study that, while positive, were not robust enough to convince the committee that they could be reproduced.

[READ MORE]

Freddie Allen is the Editor-In-Chief of the NNPA Newswire and BlackPressUSA.com. Focused on Black people stuff, positively. You should follow Freddie on Twitter and Instagram @freddieallenjr.

SIGN UP TO RECEIVE NEWS UPDATES IN YOUR INBOX


Sign up to receive the latest news in your inbox

* indicates required

Like BlackPressUSA on Facebook

Advertisement

Advertise on BlackPressUSA

advertise with blackpressusa.com